refractory acute leukemia
Showing 1 - 7 of 7
CNS Tumor, Infantile Fibrosarcoma, Recurrent Acute Leukemia Trial in Canada, United States (Larotrectinib Sulfate)
Active, not recruiting
- Central Nervous System Neoplasm
- +4 more
- Larotrectinib Sulfate
-
Birmingham, Alabama
- +81 more
Jan 24, 2023
Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in
Recruiting
- Recurrent Acute Leukemia
- +16 more
- Acetaminophen
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 22, 2022
Acute Myeloid Leukemia, Refractory Acute Leukemia, Relapsed Adult AML Trial in Suzhou (CAHAG regimen, Placebo regimen)
Recruiting
- Acute Myeloid Leukemia
- +2 more
- CAHAG regimen
- Placebo regimen
-
Suzhou, Jiangsu, ChinaThe First Affliated Hospital of Soochow University
Oct 10, 2021
Acute Myeloid Leukemia With FLT3/ITD Mutation, Recurrent Acute Myeloid Leukemia, Refractory Acute Leukemia Trial in Houston
Recruiting
- Acute Myeloid Leukemia With FLT3/ITD Mutation
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 13, 2020
Relapsed Acute Leukemia, Refractory Acute Leukemia Trial in Philadelphia (Bortezomib with mitoxantrone, etoposide and
Completed
- Relapsed Acute Leukemia
- Refractory Acute Leukemia
- Bortezomib with mitoxantrone, etoposide and cytarabine
- +2 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Apr 23, 2018
Refractory Acute Leukemia Trial in Jerusalem (Allogeneic hematopoietic stem-cell-transplantation)
Unknown status
- Refractory Acute Leukemia
- Allogeneic hematopoietic stem-cell-transplantation
-
Jerusalem, IsraelHadassah Medical Organization
Feb 18, 2016
Relapsed Acute Leukemia, Refractory Acute Leukemia, High-Risk Myelodysplasia Trial in Baltimore, New York (PD 0332991)
Terminated
- Relapsed Acute Leukemia
- +2 more
- PD 0332991
-
Baltimore, Maryland
- +1 more
Aug 30, 2013